Caroline Hroncich

UBM Americas

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.


Supreme Court Rules in Amgen v. Sandoz

The landmark decision determined that biosimilar makers can notify manufacturers before receiving FDA approval.

FDA Asks Endo to Remove Opioid From Market

FDA asked Endo Pharmaceuticals to remove Opana ER from the market, citing the potential for abuse.

Amgen Files Lawsuit Against FDA

Amgen filed a complaint against FDA claiming the agency unlawfully denied the company pediatric exclusivity for its secondary hyperparathyroidism treatment Sensipar.